Literature DB >> 11035057

Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase.

E Hooijberg1, J J Ruizendaal, P J Snijders, E W Kueter, J M Walboomers, H Spits.   

Abstract

Replicative senescence of T cells is correlated with erosion of telomere ends. Telomerase plays a key role in maintaining telomere length. Therefore, it is thought that telomerase regulates the life span of T cells. To test this hypothesis, we have over-expressed human telomerase reverse transcriptase in human CD8(+) T cells. Ectopic expression of human telomerase reverse transcriptase led to immortalization of these T cells, without altering the phenotype and without loss of specificity or functionality. As the T cells remained dependent on cytokines and Ag stimulation for their in vitro expansion, we conclude that immortalization was achieved without malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035057     DOI: 10.4049/jimmunol.165.8.4239

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Immortalization of human and rhesus macaque primary antigen-specific T cells by retrovirally transduced telomerase reverse transcriptase.

Authors:  Eugene V Barsov
Journal:  Curr Protoc Immunol       Date:  2011-11

3.  Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

Authors:  Juhua Zhou; Xinglei Shen; Jianping Huang; Richard J Hodes; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 4.  Aging of the immune system: how much can the adaptive immune system adapt?

Authors:  Nan-Ping Weng
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

Review 5.  Telomere and adaptive immunity.

Authors:  Nan-ping Weng
Journal:  Mech Ageing Dev       Date:  2007-12-08       Impact factor: 5.432

6.  Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

Authors:  Pauline Weder; Ton N M Schumacher; Hergen Spits; Rosalie M Luiten
Journal:  Results Immunol       Date:  2012-05-10

7.  Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions.

Authors:  Yun Lin; Amanda Damjanovic; E Jeffrey Metter; Huy Nguyen; Thai Truong; Kevin Najarro; Christa Morris; Dan L Longo; Ming Zhan; Luigi Ferrucci; Richard J Hodes; Nan-ping Weng
Journal:  Clin Sci (Lond)       Date:  2015-03       Impact factor: 6.124

8.  Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

Authors:  Alexander Röth; Gabriela M Baerlocher; Mike Schertzer; Elizabeth Chavez; Ulrich Dührsen; Peter M Lansdorp
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

Review 9.  Principles of adoptive T cell cancer therapy.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.

Authors:  Steven Russell Fauce; Beth D Jamieson; Allison C Chin; Ronald T Mitsuyasu; Stan T Parish; Hwee L Ng; Christina M Ramirez Kitchen; Otto O Yang; Calvin B Harley; Rita B Effros
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.